Iron–Gold Composites for Biodegradable Implants: In Vitro Investigation on Biodegradation and Biomineralization
Source abstract
Abstract
The biocompatibility and biodegradation of iron (Fe) make it a suitable candidate for developing biodegradable metallic implants. However, the degradation rate of Fe in a physiological environment is extremely slow and needs to be enhanced to a rate compatible with tissue growth. Incorporating noble metals improves the Fe degradation rate by forming galvanic couples. This study incorporated gold (Au) into Fe at very low concentrations of 1.25 and 2.37 μg/g to improve the degradation rate. The electrochemical corrosion test of the samples revealed that the Au-containing samples showed a four-time and nine-time faster degradation rate than pure Fe. Furthermore, the immersion test and long-term electrochemical impedance spectroscopy conducted in simulated body fluid (SBF) revealed that the Au-incorporated samples exhibited increased bioactivity and degraded faster than pure Fe. Integrating nanogold into a Fe matrix increased the in situ formation of hydroxyapatite on the sample's surface and did not cause toxicity to L929-murine fibroblast cells. It is suggested that Fe-Au composites with low concentrations of Au can be used to tailor the biodegradation rate and promote the biomineralization of Fe-based implants in the physiological environment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Orthopaedic implants and arthroplasty · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Nanomaterials Research Laboratory, School of Materials Science and Engineering, National Institute of Technology Calicut, Kozhikode 673601, India
Department of Mechanical Engineering, National Institute of Technology Calicut, Kozhikode 673601, India
School of Biotechnology, National Institute of Technology Calicut, Kozhikode 673601, India
Funding
Ministry of Education, India
References (63)
Show source-provided references
1. 10.1021/acsbiomaterials.0c0067810.1021/acsbiomaterials.0c00678 ↗
2. 10.3390/jfb804004410.3390/jfb8040044 ↗
3. 10.1016/j.pnsc.2014.08.01410.1016/j.pnsc.2014.08.014 ↗
4. 10.3390/met807053210.3390/met8070532 ↗
5. 10.1021/acsbiomaterials.1c0161210.1021/acsbiomaterials.1c01612 ↗
6. 10.1007/S40204-022-00189-410.1007/S40204-022-00189-4 ↗
7. 10.1016/J.MSEC.2008.12.01910.1016/J.MSEC.2008.12.019 ↗
8. 10.1016/J.BIOADV.2022.21279210.1016/J.BIOADV.2022.212792 ↗
9. 10.1021/acsami.1c1630710.1021/acsami.1c16307 ↗
10. 10.1016/j.jot.2015.08.00310.1016/j.jot.2015.08.003 ↗
11. 10.1177/228080001775035910.1177/2280800017750359 ↗
12. 10.1016/j.actbio.2010.02.02810.1016/j.actbio.2010.02.028 ↗
13. 10.1021/acsbiomaterials.8b0156310.1021/acsbiomaterials.8b01563 ↗
14. 10.1016/J.ACTBIO.2019.07.03810.1016/J.ACTBIO.2019.07.038 ↗
15. 10.1002/jbm.a.3222410.1002/jbm.a.32224 ↗
16. 10.1016/J.BIOACTMAT.2020.09.01310.1016/J.BIOACTMAT.2020.09.013 ↗
17. 10.1016/j.actbio.2010.01.00810.1016/j.actbio.2010.01.008 ↗
18. 10.1021/acsami.8b1712510.1021/acsami.8b17125 ↗
19. 10.1021/acsbiomaterials.8b0118810.1021/acsbiomaterials.8b01188 ↗
20. 10.1016/j.actbio.2007.09.01210.1016/j.actbio.2007.09.012 ↗
21. 10.4172/2155-952X.100017810.4172/2155-952X.1000178 ↗
22. 10.1016/j.msec.2020.11112910.1016/j.msec.2020.111129 ↗
23. 10.1016/j.msec.2017.05.10010.1016/j.msec.2017.05.100 ↗
24. 10.1021/acsami.7b1520610.1021/acsami.7b15206 ↗
25. 10.1021/acsbiomaterials.8b0149710.1021/acsbiomaterials.8b01497 ↗
26. 10.1016/j.msec.2012.10.00910.1016/j.msec.2012.10.009 ↗
27. 10.1002/jbm.a.3515510.1002/jbm.a.35155 ↗
28. 10.1016/j.apsusc.2018.05.06610.1016/j.apsusc.2018.05.066 ↗
29. 10.1016/j.bioactmat.2016.12.00110.1016/j.bioactmat.2016.12.001 ↗
30. 10.1088/2053-1591/ab45b910.1088/2053-1591/ab45b9 ↗
31. 10.1021/acsbiomaterials.0c0026310.1021/acsbiomaterials.0c00263 ↗
32. 10.1016/j.colsurfb.2016.01.06510.1016/j.colsurfb.2016.01.065 ↗
33. 10.1016/j.surfcoat.2017.01.05110.1016/j.surfcoat.2017.01.051 ↗
34. 10.1016/J.MTCOMM.2022.10349210.1016/J.MTCOMM.2022.103492 ↗
35. 10.1002/JBM.A.3192410.1002/JBM.A.31924 ↗
36. 10.1002/jbm.a.3292810.1002/jbm.a.32928 ↗
37. 10.1016/j.msec.2014.12.05310.1016/j.msec.2014.12.053 ↗
38. 10.1002/jbm.b.3338910.1002/jbm.b.33389 ↗
39. 10.1016/j.msec.2013.10.02310.1016/j.msec.2013.10.023 ↗
40. 10.1039/c6ra20594a10.1039/c6ra20594a ↗
41. 10.1088/2053-1591/ab4d8310.1088/2053-1591/ab4d83 ↗
42. 10.1016/J.MSEC.2014.05.01410.1016/J.MSEC.2014.05.014 ↗
43. 10.1080/02670836.2016.115234810.1080/02670836.2016.1152348 ↗
44. 10.1016/j.biomaterials.2006.01.01710.1016/j.biomaterials.2006.01.017 ↗
45. ASTM International · 2017
46. ISO 10993-5:2009 - Biological Evaluation of Medical Devices ─ Part 5: Tests for in Vitro Cytotoxicity, 2009.
47. 10.1039/C4CC02492C10.1039/C4CC02492C ↗
48. 10.1097/OPX.0b013e3181da863e10.1097/OPX.0b013e3181da863e ↗
49. 10.1038/srep1119410.1038/srep11194 ↗
50. 10.1016/J.JMA.2020.12.00210.1016/J.JMA.2020.12.002 ↗
51. 10.1088/2053-1591/ab45b910.1088/2053-1591/ab45b9 ↗
52. 10.1007/BF0201253810.1007/BF02012538 ↗
53. 10.1016/J.SURFCOAT.2022.12891410.1016/J.SURFCOAT.2022.128914 ↗
54. 10.1038/s41598-018-27752-z10.1038/s41598-018-27752-z ↗
55. 10.1016/J.MEX.2018.09.01510.1016/J.MEX.2018.09.015 ↗
56. 10.1016/j.colsurfb.2016.05.07310.1016/j.colsurfb.2016.05.073 ↗
57. Zhang J. H. · Chin. J. Physiol. · 1998 · 41 · 121
58. 10.1016/J.ADDMA.2022.10269410.1016/J.ADDMA.2022.102694 ↗
59. 10.1016/J.NANOEN.2020.10482510.1016/J.NANOEN.2020.104825 ↗
60. Ahmad Z. · 2006 · 12010.1016/B978-075065924-6/50005-2 ↗
61. 10.3390/ma911092810.3390/ma9110928 ↗
62. 10.1038/srep2362710.1038/srep23627 ↗
63. 10.1016/j.bioactmat.2021.07.00310.1016/j.bioactmat.2021.07.003 ↗